S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA

S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA

Bibliographic Details
Main Authors:	Chung Kok, Verity Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah White, Susan Branford, David Yeung, Timothy Hughes
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000967516.90725.6e

Similar Items

Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib
by: Chung H. Kok, et al.
Published: (2023-09-01)

Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia
by: Adelina Fernandes, et al.
Published: (2022-01-01)

NGS in CML - New standard diagnostic procedure?
by: Susan Branford, et al.
Published: (2019-06-01)

Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients
by: Ulf Schmitz, et al.
Published: (2020-12-01)

PHF6 mutation is associated with poor outcome in acute myeloid leukaemia
by: Kexiu Huang, et al.
Published: (2023-02-01)

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
by: Haneen Banjar, et al.
Published: (2017-01-01)

Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
by: Shady Adnan Awad, et al.
Published: (2022-04-01)

SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
by: Edwige Voisset, et al.
Published: (2020-07-01)

Acute Myeloid Leukaemia with Plasmacytosis
by: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
Published: (2016-12-01)

Exploring the acute myeloid leukaemias
by: TB Thapa
Published: (2013-10-01)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
by: Karamitros, D, et al.
Published: (2016)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
by: Sweeney, C
Published: (2021)

South African study of blast phase chronic myeloid leukaemia: A poor prognostic outlook
by: Katherine E. Hodkinson, et al.
Published: (2022-05-01)

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
by: Govinda Poudel, et al.
Published: (2022-07-01)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
by: Guinn, B, et al.
Published: (2005)

Myeloid Metaplasia of Spleen in Hookworm Disease
by: W. O. Cruz
Published: (1934-06-01)

Molecular Mechanisms and Therapies of Myeloid Leukaemia
by: Elliott Brown, et al.
Published: (2022-06-01)

Chronic myeloid leukaemia with marked thrombocytosis
by: Jun Ooi, et al.
Published: (2021-02-01)

Mortality in paediatric acute myeloid leukaemia
Published: (2020-10-01)

Adhesion Deregulation in Acute Myeloid Leukaemia
by: Alicja M. Gruszka, et al.
Published: (2019-01-01)

Wnt Signalling in Acute Myeloid Leukaemia
by: Alicja M. Gruszka, et al.
Published: (2019-11-01)

Orbital deposit in acute myeloid leukaemia
by: Seal G, et al.
Published: (1973-01-01)

Unprecedented behaviour of chronic myeloid leukaemia
by: Balambika RG, et al.
Published: (2016-07-01)

Bilateral proptosis with acute myeloid leukaemia
by: Hafeez Ahmad S, et al.
Published: (1971-01-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines
by: Monika M. Kutyna, et al.
Published: (2023-02-01)

Redefining myeloid cell subsets in murine spleen
by: Ying eHey, et al.
Published: (2016-01-01)

Generation of Myeloid Cells in Cancer: The Spleen Matters
by: Chong Wu, et al.
Published: (2020-06-01)

ED151, A Flawed Approach
by: Brian Andrew, et al.
Published: (2007-09-01)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

C/EBPalpha mutations in acute myeloid leukaemias.
by: Nerlov, C
Published: (2004)

Immunological weapons against acute myeloid leukaemia.
by: Galea-Lauri, J
Published: (2002)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (1996)

New Therapeutic Approaches for Acute Myeloid Leukaemia
by: Ruth M Risueno, et al.
Published: (2021-06-01)

The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
by: Carini Picardi Morais de Castro, et al.
Published: (2021-08-01)

Two ophthalmic presentations of chronic myeloid leukaemia
by: Miles Kiernan, et al.
Published: (2022-08-01)

Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
by: Jonathan R. Sillar, et al.
Published: (2019-10-01)